TCL Archive Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies April 25, 1986
TCL Archive Retrospective Data Clean-Up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”. February 15, 2002
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer February 21, 2003
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. September 30, 2005
